An interventional study of Moroccan-Adapted Nutritional Plan in Type 2 Diabetes (T2DM), sponsored by Avicenna Military Hospital. Active, not recruiting at 1 site in Morocco. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-12.
Sponsored by Avicenna Military Hospital · Not applicable, Interventional, and Treatment
The goal of this study is to learn if a nutritional intervention adapted to Moroccan dietary habits can improve blood sugar control in adults with Type 2 Diabetes. The main questions it aims to answer are:
Participants will:
This study follows a quasi-experimental, before-after design conducted in a clinical setting. The research is structured to evaluate the metabolic and anthropometric response of Type 2 Diabetic (T2D) patients to a culturally tailored nutritional intervention. The trial is longitudinal, spanning a total duration of 180 days per participant.
Intervention Phases:
The protocol is divided into distinct chronological stages to capture both baseline data and intervention outcomes:
Data collection and Scientific tools:
The study utilizes high-precision monitoring tools to ensure data reliability:
Statistical Analysis Plan Data will be analyzed using a within-subject comparison. Descriptive statistics will summarize baseline characteristics. Paired t-tests and ANOVA will be employed to compare glycemic and anthropometric variables across the four time points (T0, T7, T90, T180), with a significance level set to p\<0.05. Additionally, Pearson or Spearman correlation tests and Artificial Intelligence techniques will examine the association between specific Moroccan dietary patterns and glycemic fluctuations.
10,371 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,406 are open to participants now.
This study's planned enrollment of 50 is below the median of 80 across 8,350 interventional studies indexed under Diabetes Mellitus, Type 2.
Browse Diabetes Mellitus, Type 2 studies →Avicenna Military Hospital is the lead sponsor of 8 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
HbA1c
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A single group of 50 Type 2 Diabetic patients will participate in a four-stage intervention over 180 days. * Phase 1 (Baseline): Participants will follow their usual, free diet for 7 days while monitored by Continuous Glucose Monitoring (CGM) and food diaries to establish a baseline. * Phase 2 (Intervention): Participants receive personalized nutritional directives specifically adapted to traditional Moroccan dietary habits and culinary practices. * Phase 3 (Follow-up): Continuous monitoring and periodic consultations (at Day 14, Day 90, and Day 180) to adjust the intervention, measure metabolic changes (HbA1c), and evaluate anthropometric parameters.
Behavioral: Moroccan-Adapted Nutritional Plan
The intervention consists of a structured diet plan that integrates traditional Moroccan ingredients and cooking methods while optimizing for glycemic control. It involves: * Personalized meal planning based on individual food diaries. * Education on carbohydrate counting and portion sizes within the Moroccan culinary context. * Use of Continuous Glucose Monitoring (CGM) data to provide real-time feedback on how specific Moroccan meals affect the participant's glucose levels.
Change in Interstitial Glucose Levels
Evaluation of the impact of the Moroccan-adapted nutritional intervention on daily glucose fluctuations. This is measured using a Continuous Glucose Monitoring (CGM) system to record real-time glucose data.
Time frame: Baseline (Day 0 to Day 7) compared to the final follow-up at Day 180.
Change in HbA1c
Measurement of glycated hemoglobin to assess long-term glycemic control through laboratory samples.
Time frame: Baseline (Day 0) and Day 180.
Change in Body Mass Index (BMI)
Calculation of BMI based on weight and height measurements.
Time frame: Baseline (Day 0) and Day 180.
Change in Waist Circumference
Anthropometric measurement of the waist to evaluate changes in abdominal adiposity.
Time frame: Baseline (Day 0) and Day 180.
Change in Body Composition
Assessment of body fat and lean mass using bioelectrical impedance.
Time frame: Baseline (Day 0) and Day 180.
Dietary Adherence
Evaluation of changes in dietary habits and adherence to the personalized Moroccan-adapted recommendations using food diaries.
Time frame: Baseline (Day 7) compared to Day 180.
Plan to share: Yes — Individual participant data that underlie the results reported in this study and the final article (text, tables, figures, and appendices), after de-identification, will be made available to researchers who provide a methodologically sound proposal. Request should be directed to the corresponding author. To gain access, data requestors will need to sign a data access agreement.
Supporting information: Study protocol, Statistical analysis plan
Time frame: Data will be available beginning 6 months after publication of the results and ending 3 years after publication.
Access criteria: Data will be shared with researchers who provide a methodologically sound proposal and after signing a data access agreement to ensure ethical use and patient anonymity.
No publications or documents are linked to this record.
This study is active, not recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Avicenna Military Hospital